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Allosteric inhibition of a stem cell  
RNA-binding protein by an intermediary 
metabolite
Carina C Clingman, Laura M Deveau, Samantha A Hay, Ryan M Genga,  
Shivender MD Shandilya, Francesca Massi, Sean P Ryder*
Department of Biochemistry and Molecular Pharmacology, University of Massachusetts 
Medical School, Worcester, United States
Abstract Gene expression and metabolism are coupled at numerous levels. Cells must sense and 
respond to nutrients in their environment, and specialized cells must synthesize metabolic products 
required for their function. Pluripotent stem cells have the ability to differentiate into a wide variety 
of specialized cells. How metabolic state contributes to stem cell differentiation is not understood. 
In this study, we show that RNA-binding by the stem cell translation regulator Musashi-1 (MSI1) is 
allosterically inhibited by 18–22 carbon ω-9 monounsaturated fatty acids. The fatty acid binds to the 
N-terminal RNA Recognition Motif (RRM) and induces a conformational change that prevents RNA 
association. Musashi proteins are critical for development of the brain, blood, and epithelium.  
We identify stearoyl-CoA desaturase-1 as a MSI1 target, revealing a feedback loop between ω-9 
fatty acid biosynthesis and MSI1 activity. We propose that other RRM proteins could act as metabolite 
sensors to couple gene expression changes to physiological state.
DOI: 10.7554/eLife.02848.001
Introduction
The RNA-binding protein Musashi-1 (MSI1) is expressed in stem and progenitor cells of neural and 
epithelial lineage. In the central nervous system, MSI1 is expressed in astrocytes and committed glial 
and neural progenitor cells, but not in mature neurons and oligodendrocytes (Figure 1A; Kaneko 
et al., 2000; Dobson et al., 2008). In histological studies of neural and epithelial tissues, MSI1 is 
routinely used as a marker for stem and progenitor cells (Johnson et al., 2010). Analysis in mice and 
primary cells shows that MSI1 regulates neural development. Msi1−/− knockout mice are uncoordi-
nated, ataxic, develop hydrocephaly, and die within 1–2 months after birth (Sakakibara et al., 2002). 
Their brains are small, contain an expansion of early lineage progenitor cells, and display fewer mature 
cell types than normal (Sakakibara et al., 2002). Embryonic neurospheres cultured from Msi1−/− mouse 
brains have a reduced capacity to differentiate into mature neurons and oligodendrocytes (Sakakibara 
et al., 2002). In primary oligodendrocyte progenitor cells, MSI1 promotes progenitor cell survival and 
prevents differentiation into mature oligodendrocytes (Dobson et al., 2008). The phenotype and 
expression pattern reveal that MSI1 plays an early role in regulating neurogenesis and gliogenesis.
MSI1 contains two RNA recognition Motifs (RRMs) and is homologous to Drosophila melanogaster 
Musashi, a post-transcriptional regulatory protein that guides external sensory bristle patterning in 
flies (Sakakibara et al., 1996). In vitro SELEX experiments identified a series of aptamer sequences 
that bind to MSI1 (Imai et al., 2001). Visual inspection identified a consensus sequence (G/A)U1–3AGU 
that was present in most but not all of the aptamers. A number of MSI1 targets have been identified 
by co-immunoprecipitation, including NUMB, a repressor of NOTCH signaling. Numb transcripts 
harbor MSI1 consensus elements in the 3′-UTR (Imai et al., 2001). MSI1 interacts with the Numb 
3′-UTR in vitro, and Numb mRNA co-immunoprecipitates with MSI1 in transiently transfected NIH 3T3 
*For correspondence: sean.
ryder@umassmed.edu
Competing interests: The 
authors declare that no 
competing interests exist.
Funding: See page 22
Received: 19 March 2014
Accepted: 15 June 2014
Published: 16 June 2014
Reviewing editor: Douglas L 
Black, Howard Hughes Medical 
Institute, University of California, 
Los Angeles, United States
 Copyright Clingman et al. 
This article is distributed under 
the terms of the Creative 
Commons Attribution License, 
which permits unrestricted use 
and redistribution provided that 
the original author and source 
are credited.
RESEARCH ARTICLE
Biochemistry | Biophysics and structural biology
Clingman et al. eLife 2014;3:e02848. DOI: 10.7554/eLife.02848 2 of 26
Research article
cells. Overexpression of MSI1 in NIH 3T3 cells decreases NUMB protein levels without affecting Numb 
mRNA and reduces the expression of a luciferase reporter in a 3′-UTR dependent manner (Imai et al., 
2001). Together, the results show that MSI1 negatively regulates Numb mRNA translation. In contrast, 
MSI1 acts as a translational activator in Xenopus laevis oocytes, where it modulates cell cycle progres-
sion by regulating mRNA encoding the proto-oncogene Mos (Charlesworth et al., 2006).
MSI1 also promotes proliferation of numerous cancers of the brain and epithelial tissues (Toda 
et al., 2001; Hemmati et al., 2003; Yokota et al., 2004; Sanchez-Diaz et al., 2008; Sureban et al., 
2008). MSI1 depletion in medulloblastoma and colorectal tumors results in decreased proliferation 
and increased apoptosis (Sanchez-Diaz et al., 2008; Sureban et al., 2008). In colorectal tumors, MSI1 
depletion is accompanied by inhibition of Notch-1 and upregulation of p21WAF1, a MSI1 target involved 
in cell cycle regulation (Battelli et al., 2006; Sureban et al., 2008). Musashi-2 (MSI2) is 69% identical 
to MSI1 protein and is expressed in a partially overlapping set of tissues (Sakakibara et al., 2002). 
MSI2 regulates hematopoesis and is involved in acute myeloid leukemia (Ito et al., 2010; Kharas 
et al., 2010). In myeloid leukemia cells, MSI2 is highly expressed, and depletion results in decreased 
proliferation and increased apoptosis (Kharas et al., 2010). The crisis phase of myeloid leukemia is 
marked by low NUMB expression (Ito et al., 2010). Loss of MSI2 restores NUMB expression and 
impairs the blast crisis phase of myeloid leukemia (Ito et al., 2010). Ultimately, MSI2 expression levels 
are directly correlated with poor prognosis in myeloid leukemia patients (Kharas et al., 2010).
Because of the importance of Musashi family proteins in stem and cancer cell proliferation, 
we sought to identify a small molecule inhibitor of MSI1 RNA-binding activity. After screening more 
than 30,000 compounds, we identified four inhibitors, one of which is the intermediary metabolite 
oleic acid. Here, we characterize the specificity and mechanism of oleic acid inhibition and identify 
a novel regulatory target that enables MSI1 to act as a metabolite sensor.
Results
Small molecule screen to identify inhibitors of Musashi-1
To screen for small molecule inhibitors of MSI1 RNA-binding activity, we developed an in vitro assay 
pipeline amenable to high throughput measurements. First, we tested the ability of a purified, his6-tagged 
MSI1 dual RRM construct (amino acids 7–192, Figure 1—figure supplement 1A) to bind a fragment 
of a previously identified SELEX aptamer (CCCR005) (Imai et al., 2001) using two quantitative assays: 
fluorescence electrophoretic mobility shift (F–EMSA) and fluorescence polarization (FP, Figure 1B–D) 
eLife digest When an embryo is developing, stem cells must divide and develop into many 
specialized types of cells. However, if cell division doesn't stop, or if it restarts later in life, it can 
cause tumors to form.
Musashi-1 is a protein that binds to molecules of RNA and helps to promote cell growth during 
development: mice that lack this protein have serious brain defects and die shortly after birth. 
Musashi-1 is usually turned off in adult cells that are not dividing. Sometimes, however, it remains 
active and contributes to the growth of cancers in the brain and the gut. Reducing Musashi-1 levels 
in colon tumors slows their growth and causes the cancer cells to die.
To find a compound that would switch off Musashi-1, Clingman et al. screened more than 30,000 
compounds and identified four inhibitors. One of these was oleic acid, a fatty acid that is found in 
olive oil and other animal and plant oils. Oleic acid interacts with Musashi-1 in a way that changes 
the shape of the protein. These changes mean that Musashi-1 is no longer able to regulate the 
genes that control cell proliferation.
Clingman et al. also found that Musashi-1 promotes the activity of a particular enzyme that makes 
fatty acids; molecules that are needed in large quantities when cells are dividing. Musashi-1 appears 
to act as a ‘nutrient sensor’, turning down the activity of this enzyme in cells when levels of oleic acid 
are high, and turning up enzyme activity when oleic acid levels are low. The findings of Clingman et al. 
further reveal how our diets can affect gene expression, and may aid the development of new 
treatments against cancer.
DOI: 10.7554/eLife.02848.002
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Figure 1. MSI1 is inhibited by monounsaturated fatty acids. (A) Pattern of MSI1 (blue) in the CNS. (B–D) EMSA and FP of MSI1 binding to RNA aptamer 
CCCR005 (AGCGUUAGUUAUUUAGUUCG). EMSA data (red line) were fit to the Hill equation where all shifted species were fit as an aggregate. FP data 
(black line) were fit to a two-site binding model. (E and F) Assay scheme for the inhibitor screen (E) and F–EMSA dose responses with hits identified 
from the small molecule screens (E) and oleic and elaidic acid (F). Each gel is one representative experiment of at least three independent experiments. 
No compound and no protein lanes identify the position of bound and free RNA migration, respectively.
DOI: 10.7554/eLife.02848.003
The following figure supplements are available for figure 1:
Figure supplement 1. 
DOI: 10.7554/eLife.02848.004
Figure supplement 2. RNA binding specificity and inhibition by specific fatty acids is conserved in MSI2. 
DOI: 10.7554/eLife.02848.005
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(Pagano et al., 2011). MSI1 binds with high affinity to the aptamer fragment, which contains two 
copies of the consensus sequence. Next, we optimized the FP assay for use in high throughput 
screens. We used this assay to screen two small molecule libraries: the 1280-compound Sigma Library 
of Pharmacologically Active Compounds (LOPAC) and the 30,000-compound Chembridge library 
(Figure 1E; Table 1A). Inhibitors identified in the screen were validated by dose response measurements 
using both the FP and F–EMSA assays (Figure 1E,F).
Four candidate inhibitors were identified. The weakest inhibitor was the Chembridge compound 
7409829 (Ki, app, FP = 15 ± 2.8 µM, Ki, app, F–EMSA = 54 ± 22 µM). The most potent inhibitor was 
aurintricarboxylic acid (ATA, Ki, app, FP = 230 ± 30 nM, Ki, app, F–EMSA = 1.55 ± 0.14 µM), a compound that 
readily polymerizes in aqueous solution to form a polyanion. This compound has been identified 
in many high throughput small molecule assays as a non-specific inhibitor of protein–nucleic acid 
interactions (Lam et al., 1995). The next inhibitor was GW7647, a PPARα agonist (Berger and Moller, 
2002). PPARα is a nuclear hormone receptor that is activated by long chain unsaturated fatty acids 
(Gottlicher et al., 1992; Bocos et al., 1995; Forman et al., 1997; Kliewer et al., 1997). The Ki, app for 
this compound was 6.5 ± 0.4 µM by FP and 21 ± 0.8 µM by F–EMSA. The final inhibitor was oleic 
acid, an eighteen-carbon monounsaturated fatty acid with one double bond located nine carbons 
from the aliphatic—omega—end of the molecule (18:1, ω-9). The apparent Ki of this compound 
was 1.2 ± 0.4 µM by FP and 1.4 ± 0.7 µM by F–EMSA, and we observed decreased affinity for the 
RNA aptamer with increasing concentrations of oleic acid (Figure 1F, Figure 1—figure supplement 1B). 
The Ki, app is approximately two orders of magnitude below the critical micelle concentration (CMC) 
in our equilibration buffer (pH 8.0) as measured by N-phenyl-1-naphthylamine (CMC ≥ 75 ± 8 µM, 
Figure 1—figure supplement 1C).
Oleic acid has been screened in 754 bioassays reported in the PubChem database. Of these, oleic 
acid scored as positive in 4% of the assays. It should be noted that this figure overestimates the hit rate 
because it includes multiple bioassays that target the same protein. For example, oleic acid scored as 
a positive in eleven bioassays targeting fatty acid binding proteins (FABP) and seven assays that target 
membrane-associated potassium channels. Both are known to be sensitive to fatty acids (Capaldi et al., 
2006; Boland and Drzewiecki, 2008). Other proteins responsive to oleic acid include fatty acid 
synthase, estrogen synthase, factor VIIa complex, and enterotoxin. It also scored positive in a screen 
for membrane permeant biomolecules. In total, only 14 unique proteins are responsive to oleic acid. 
This suggests that oleic acid inhibition is specific.
MSI1 is specifically inhibited by 18–22 carbon ω-9 monounsaturated 
fatty acids
Oleic acid is the most abundant fatty acid in body fat and is produced by mature oligodendrocytes 
during myelination (Martinez and Mougan, 1998). Cells can produce almost any fatty acid by 
modifying existing fatty acids through precise metabolic pathways. Because oleic acid is structurally 
related to a large number of fatty acids, we obtained a library of fatty acids and analogs to assess the 
specificity of inhibition (Figure 1F; Table 1). First, we measured inhibition by longer omega-9 mono-
unsaturated fatty acids using the FP and F–EMSA dose response assays. Eicosenoic acid (20:1, ω-9) 
inhibited MSI1 with a potency similar to oleic acid (Ki, app, FP = 1.2 ± 0.4 µM, Ki, app, F–EMSA = 1.7 ± 0.6 µM). 
Erucic acid (22:1, ω-9) was a stronger inhibitor (Ki, app, FP = 640 ± 150 nM, Ki, app, F–EMSA = 820 ± 30 nM), 
and nervonic acid (24:1, ω-9) inhibited more weakly (Ki, app, FP = 47 ± 25 µM, Ki, app, F–EMSA = 23 ± 8 µM). 
Second, we assessed truncations and modifications of the aliphatic end of the fatty acid. Removing 
two carbons (palmitoleic acid, 16:1, ω-7) had a moderate effect on inhibition (Ki, app, FP = 5.3 ± 0.5 µM, 
Ki, app, F–EMSA = 12 ± 0.9 µM). The presence of a hydroxyl group at carbon 12 (ricinoleic acid, 12-hydroxy-
oleic acid) had a stronger effect; inhibition is barely detectable by FP and reduced 15-fold in F–EMSA 
measurements (Ki, app, F–EMSA = 18 ± 9). Third, we assessed esterification or other modification of the 
carboxylate group. Oleamide, ethyl oleate, and 4-methylumbelliferyl oleate failed to inhibit RNA-
binding. In contrast, the presence of a Coenzyme A (CoA) substituent was apparently tolerated, 
although we noted some deacylation of acyl-CoA stocks by thin layer chromatography. Fourth, we 
assessed the requirement for the ω-9 double bond. Stearic (18:0), palmitic (16:0), and myristic (14:0) 
acids failed to inhibit MSI1 RNA-binding activity, indicating that the ω-9 double bond is required. 
Surprisingly, the orientation of the double bond is also critical. Elaidic acid (18:1, ω-9 trans) has the 
same molecular weight as oleic acid, and nearly identical refractive index and molar aqueous solubility 
(∼10 mM at pH 8.0), but its ω-9 double bond is trans rather than cis. Elaidic acid did not inhibit MSI1 
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Table 1. Structure-activity relationship analysis demonstrates specificity of inhibition
A
Compound name CID Screen score FP Ki, app (µM)
F–EMSA  
Ki, app (µM)
Chembridge 7409829 28425 0.045 15 ± 2.8 54 ± 22
Aurintricarboxylic Acid (ATA) 2259 0.053 0.23 ± 0.03 1.5 ± 0.14
GW7647 3397731 −0.028 6.5 ± 0.4 21 ± 0.8
Oleic Acid 445639 −0.005 1.2 ± 0.4 1.4 ± 0.7
B
Compound name Structure Code FP Ki, app (µM)
F–EMSA  
Ki, app (µM)
Oleic acid 18:1 ω-9 1.2 ± 0.4 1.4 ± 0.7
Eicosenoic acid 20:1 ω-9 1.2 ± 0.4 1.7 ± 0.6
Erucic acid 22:1 ω-9 0.64 ± 0.2 0.82 ± 0.03
Nervonic acid 24:1 ω-9 47 ± 30 23 ± 8
Palmitoleic acid 16:1 ω-7 5.3 ± 0.5 13 ± 0.9
Linoleic acid 18:2 ω-6, 9 2.2 ± 0.2 1.2 ± 0.03
Arachidonic acid 20:4 ω-6, 9, 12, 15 3.0 ± 0.2 1.1 ± 0.3
Oleoyl-CoA (18:1 ω-9) 8.1 ± 0.3 4.0 ± 0.2
Erucyl-CoA (18:1 ω-9) 4.1 ± 0.9 0.62 ± 0.2
Ricinoleic acid (18:1 ω-9) No inh. 18 ± 9
Oleamide (18:1 ω-9) No inh. No inh.
Ethyl oleate (18:1 ω-9) No inh. No inh.
4-Methylumbelliferyl Oleate (18:1 ω-9) No inh. No inh.
Elaidic acid 18:1(trans) No inh. No inh.
Stearic acid 18:0 No inh. No inh.
Palmitic acid 16:0 No inh. No inh.
Myristic acid 14:0 No inh. No inh.
(A) Small molecule screen hits. Compound ID (CID) refers to each compound's LOPAC identification number. Screen 
scores were calculated by normalizing the polarization value of each compound to the no protein and no compound 
controls, as described in the supplemental methods. After the screen was complete, compounds that scored as hits 
were confirmed by FP and F–EMSA dose response experiments. Apparent inhibition constants (Ki, app) are the average 
and standard deviation of at least three independent experiments. (B) The code = carbon number:number of double 
bonds, followed by the position of the double bonds from the aliphatic end of the fatty acid. Where a fatty acid is 
modified, the parental fatty acid numerical code is given in parentheses for comparison purposes. FP and F-EMSA 
dose response results are reported as the average and standard deviation of at least three independent experiments.
DOI: 10.7554/eLife.02848.006
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(Figure 1F). Linoleic (18:2, ω-9, ω-6) and arachidonic (20:4, ω-12, ω-9, ω-6, ω-3) polyunsaturated 
fatty acids also inhibit MSI1, but with a weaker apparent inhibition constant (Linoleic acid: Ki, app, FP = 2.2 
± 0.2 µM, Ki, app, F–EMSA = 1.2 ± 0.03 µM; Arachidonic acid: Ki, app, FP = 3.0 ± 0.2 µM, Ki, app, F–EMSA = 1.1 ± 0.3 
µM). We conclude that omega-9 cis unsaturated fatty acids between 18 and 22 carbons specifically 
inhibit MSI1 RNA-binding activity and identify erucic acid as the most potent inhibitor (Table 1). MSI2 
was inhibited with similar specificity (Figure 1—figure supplement 2).
Oleic acid directly interacts with the RRM1 of MSI1 to effect inhibition
In principle, inhibitory fatty acids could inhibit by interacting with either MSI1 or its RNA target. 
We hypothesized that if the fatty acid bound to the RNA-binding domain of MSI1, the interaction 
might alter the local environment of its single tryptophan (W29), leading to a change in the intrinsic 
fluorescence (Vivian and Callis, 2001). To test this hypothesis, we titrated oleic acid or elaidic acid 
(trans-oleic acid) into recombinant MSI1 protein or an n-acetyl-L-tryptophanamide (NATA) control and 
measured tryptophan fluorescence. Titration of oleic acid, but not elaidic acid, strongly quenched 
tryptophan fluorescence and altered the emission intensity curve shape from 300 to 400 nm (Figure 2A, 
Figure 2—figure supplement 1A–D). Neither compound affected the fluorescence of NATA. 
In our buffer system, the maximal emission for both NATA and MSI1 is 350 nm (Figure 2—figure 
supplement 1A–D). We fit the emission at 350 nm to a quadratic, bimolecular association model in order 
to determine the apparent dissociation constant. The Kd, app of oleic acid was 2.6 ± 1 µM, essentially 
identical to the Ki, app determined by FP and F–EMSA dose response experiments (Table 1A; Figure 2A). 
Our data are consistent with inhibition resulting from a direct association of oleic acid with the MSI1 
protein.
The NMR structures of MSI1 RRM1 and RRM2 in the absence and presence of RNA show that both 
domains adopt the canonical RRM fold in which an anti-parallel beta sheet is buttressed by two alpha 
helices (Figure 2B; Nagata et al., 1999; Miyanoiri et al., 2003; Ohyama et al., 2011). In RRM domain 
proteins, the beta sheet surface typically forms the RNA-binding platform (Figure 2B; Kielkopf et al., 
2004; Clery et al., 2008). In the RNA-bound structure, several conserved amino acids located on the 
beta sheet surface and loops make sequence-specific contacts to the RNA (Ohyama et al., 2011). 
Notably, W29 directly contacts RNA by stacking on the first purine nucleotide. Our data reveal that 
fatty acid binding causes W29 fluorescence quenching, suggesting that binding changes the environ-
ment surrounding this amino acid. As such, fatty acid binding may inhibit MSI1 RNA-binding by an 
allosteric mechanism.
To assess whether oleic acid association induces a change in MSI1 secondary structure, we col-
lected circular dichroism spectra as a function of fatty acid treatment. We observe a decrease in mean 
residue ellipticity centered around wavelength 220 nm upon treatment with oleic acid but not elaidic 
acid (Figure 2C, Figure 2—figure supplement 1E). To determine whether the spectral changes cor-
respond to a change in oligomerization state, we performed velocity sedimentation analytical ultra-
centrifugation experiments (Demeler et al., 2011). We observe no significant change in the velocity 
sedimentation profile of MSI1 by van Holde-Weischet analysis after adding either oleic acid or elaidic 
acid, and the predominant species remains monomeric (Figure 2D) (Demeler and van Holde, 2004; 
Demeler et al., 2011). We conclude that oleic acid binding alters the secondary structure of MSI1, but 
this transition does not appear to induce aggregation at concentrations below the CMC.
After examining the published NMR structures, we were intrigued to note a hydrophobic cavity on 
the alpha-helical surface of RRM1, opposite the RNA-binding surface (Figure 2B) and adjacent to W29 
(Nagata et al., 1999; Miyanoiri et al., 2003). MSI1 RRM2 does not have this feature. We hypothesized 
that this cavity comprises the fatty acid binding site. To test this idea, we first asked whether RRM1 
is sufficient for ω-9 fatty acid inhibition. We purified his6-tagged MSI1 RRM1 (amino acids 7-103) and 
used FP and F–EMSA to determine whether RRM1 is sufficient for both RNA binding and inhibition by 
oleic acid. RRM1 bound to the aptamer RNA with an apparent Kd of 75.2 ± 10 nM by FP (Figure 2—
figure supplement 2A). Addition of oleic acid but not elaidic acid inhibits RNA-binding activity with 
similar Ki, app compared to the full RNA-binding domain (Figure 2—figure supplement 2B). Thus, 
RRM1 is sufficient for RNA recognition and fatty acid inhibition.
Next, we prepared an 15N labeled sample of RRM1 for NMR spectroscopy, collected an 15N-1H 
HSQC spectrum, and titrated aptamer RNA to identify amide proton chemical shift differences 
associated with RNA binding (Figure 2—figure supplement 2C). The majority of the chemical shift 
differences map to the β-sheet surface and the loops, which is typical for RRM proteins. Notably, 
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Figure 2. MSI1 inhibition is allosteric. (A) MSI1 tryptophan fluorescence at 350 nm as a function of oleic and elaidic acid. The Kd, app, Ki, app, and Hill 
parameters are the average and standard deviation of three independent replicates. (B) Ribbon model of MSI1 RRM1 (top). Space-filling model of MSI1 
RRM1 (middle) and RRM2 (bottom) (Nagata et al., 1999; Miyanoiri et al., 2003). Left, β-sheet surface, right, α-helical surface. Conserved phenylalanines 
Figure 2. Continued on next page
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backbone amide protons corresponding to F23, G64, and F65, display large chemical shift changes 
upon RNA binding. In contrast, chemical shifts changes on the α helical face are small. The data are 
consistent with the model where the β-sheet surface recognizes RNA, and that binding involves a 
structural transition including F23, G64, and F65 (Ohyama et al., 2011). Next, we titrated oleic acid or 
elaidic acid into the sample of MSI1 (Figure 2—figure supplement 2D–F). We expected to observe 
chemical shift changes associated with oleic acid binding to the protein. The addition of increasing 
amounts of oleic acid did not result in significant changes in chemical shifts but in considerable 
reduction of the peak intensities and in line broadening. The largest loss of signal upon addition of 
substoichiometric concentrations of oleic acid was observed for W29, Q30, L36, C49, L50, R53, S60, 
G62, V74, T89, and K98 (Figure 2, Figure 2—figure supplement 2E,F). The observed loss of signal 
is likely due to chemical exchange between the free and bound state. As expected, we detected a 
strong loss in signal intensity across the entire protein when the concentration of oleic acid exceeded 
the CMC (75 ± 8 µM, Figure 1—figure supplement 1C and Figure 2—figure supplement 2D–F). 
The observed general loss of MSI1 signal is probably due to precipitation of the protein–oleic acid 
complex, or it could be attributed to the interaction of MSI1 with oleic acid micelles, or both. We note 
that a precipitant forms in the NMR tube at elevated oleic acid concentration. Because the CMC of 
oleic acid is below the concentration needed to make a saturated MSI1 sample (Figure 1—figure 
supplement 1C), we cannot form sufficient MSI1-oleic acid complex for NMR structural studies.
A model of the omega-9 fatty acid inhibition mechanism
Because the high concentrations needed for NMR spectroscopic studies precluded direct measure-
ment of the MSI1 fatty acid interface, we performed computational docking calculations with eicosenoic 
acid or oleic acid with MSI1 RRM1 (Table 1; Figure 3; Friesner et al., 2004, 2006). In the docked 
models, both compounds insert the ω-9 end into the cavity, form extensive contacts with the protein 
surface, and position their carboxy termini adjacent to a positively charged arginine side chain (R53 or 
R61, dependent on the model, Figure 3A,B, Figure 2—figure supplement 2D–F, Figure 3—figure 
supplement 1A). The docked model explains the specificity of inhibition. Amide and ester derivatives 
lose the negative charge and cannot form charge–charge interactions with arginine (oleamide, ethyl 
oleate). Shorter omega-7 fatty acids will not fill the hole (palmitoleic acid). Modifications of the omega 
end limit insertion into the hole (ricinoleic acid). 18 carbons enable the carboxylate to reach R53 (oleic 
acid), (Figure 3A,B, Figure 3—figure supplement 1A). 24 carbons position the group beyond the 
arginine (nervonic acid). Trans orientation of the double bond limits surface contact and prevents ori-
entation of the carboxylate towards R53 (elaidic acid). Finally, saturation of the double bond would 
require a large entropic penalty in order to adopt the necessary conformation (stearic acid).
To further assess how fatty acid binding alters the dynamics of amino acids that contribute to RNA 
recognition, we performed molecular dynamics (MD) simulations of the MSI1 RRM1 motif with and 
without oleic acid. The NMR structure of MS1 RRM1 served as the starting configuration for the free 
state (Nagata et al., 1999; Miyanoiri et al., 2003). Three different models derived by docking oleic 
acid provided the starting configurations for the oleic acid-bound state (Friesner et al., 2004, 2006). 
Each of the four simulations was equilibrated for 1 ns and data were collected during a subsequent 
30 ns trajectory. Upon oleic acid binding, MSI1 underwent a transition to a more open state characterized 
by an increase in solvent accessible surface area (SASA) and radius of gyration (Figure 4A). Direct 
visualization of the structure's time evolution showed that binding of oleic acid is associated with 
and W29 are green. Lysine and arginine residues are blue. A hydrophobic pocket exists on the RRM1 α-helical surface. (C) CD spectra of MSI1 RRM1 in 
the presence of oleic (top) or elaidic acid (bottom). (D) Envelope traces of the van Holde-Weischet analysis for analytical ultracentrifugation experiments 
of MSI1 alone (top), with oleic acid (middle) and with elaidic acid (bottom). The predominant species sediments where monomeric MSI1 would be 
expected, and there is no significant change in the sedimentation profile after addition of oleic or elaidic acid. Data are representative traces from one 
of three independent experiments.
DOI: 10.7554/eLife.02848.007
The following figure supplements are available for figure 2:
Figure supplement 1. 
DOI: 10.7554/eLife.02848.008
Figure supplement 2. 
DOI: 10.7554/eLife.02848.009
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Figure 3. (A and B) Model of RRM1 bound to oleic acid (yellow) calculated by Schrödinger GLIDE (Friesner et al., 2004; Friesner et al., 2006).  
(C) Overlay of the oleic acid bound MD simulation (gray and red) with the apo-state NMR structure (gray and blue) (Ohyama et al., 2011). (D) RNA contact 
residues (red) in loop 5, helix 2, and strand 4 of the β-sheet are perturbed in oleic acid-bound molecular dynamics simulation (Ohyama et al., 2011).  
(E and F) A representative snapshot from the MD simulation of MSI1 bound to oleic acid (white) compared to the MSI1-RNA NMR structure (blue) 
(Ohyama et al., 2011). Panel (E) shows the Gua 1 binding pocket. In the oleic-bound state, the open conformation of loop 5 (L5) orients K88 such that 
K88 cannot contact Gua 1. W29 is stacked against Q30 and unavailable for stacking against Gua 1. Interaction with the side chain of R61 stabilizes the 
conformation of W29 in the oleic-bound state. Panel (F) highlights the different conformations of residues that interact with Gua 1, Ura 2, Ade 3, and Gua 
4; represented in grey, orange, red, and purple, respectively. (G) Difference of the mean Lipari-Szabo order parameters by residue between the apo and 
Figure 3. Continued on next page
Biochemistry | Biophysics and structural biology
Clingman et al. eLife 2014;3:e02848. DOI: 10.7554/eLife.02848 10 of 26
Research article
stabilization of the C-terminus of α-helix 1, fraying of α-helix 2 at both the N- and C-termini and, in one 
trajectory, formation of an additional β-sheet in loop 5 (Figure 3C,D; Video 1). The computed proba-
bility of each residue to be in a secondary structural element (Figure 4C) supports our observations. 
Notably, the β-sheet that forms in loop 5 is absent in the MSI1 apo structure but is present in the 
structure of MSI1 bound to RNA (Figure 3D; Ohyama et al., 2011).
Analysis of the structure and dynamics of MSI1 bound to oleic acid and its comparison to the RNA-
bound structure suggests a mechanism of inhibition. Oleic acid binding stabilizes β-strand formation 
in loop 5 and alters its position relative to helix 1. The distance between the C-terminus of α-helix 
1 and loop 5 in the free and oleic acid-bound state is greater than that observed in the RNA-bound 
state (Figures 3D, Figure 4). The presence of oleic acid blocks loop 5 from approaching the C-terminus 
of α-helix 1. When loop 5 is in the more open conformation, K88 is not in position to interact with the 
first purine nucleotide of the consensus, in this case Gua1. In addition, binding of oleic acid causes 
W29 to stack against the side chain of Q30. (Figure 3E,F, Figure 4). This observation is in agreement 
with the NMR signal intensity loss observed for certain residues during oleic acid titration (Figure 2—
figure supplement 2D–F), as well as the strong quenching of MSI1 tryptophan fluorescence measured 
upon addition of oleic acid (Figure 2A, Figure 2—figure supplement 1A–D). W29 directly stacks with 
the first RNA nucleotide, stabilizing the interaction between MSI1 and RNA. Stacking is eliminated 
in the presence of oleic acid (Figure 3E,F). Finally, strand 4 is more flexible in the oleic acid-bound 
state than in free MSI1 (Figure 3E,F). Strand 4 contains several residues that directly contact RNA. The 
simulations suggest that oleic acid weakens these interactions. In contrast to our initial hypothesis, we 
do not observe a dramatic change in the dynamics of F65 in the presence of oleic acid over the time 
course of the simulations.
The circular dichroism and analytical ultracentrifugation data (Figure 2C,D, Figure 2—figure 
supplement1E) are consistent with a net gain in secondary structure upon oleic acid binding, 
as predicted by the MD simulation (Figure 3, Figure 4). In addition, the change in tryptophan fluores-
cence observed upon oleic acid but not elaidic acid treatment is consistent with the changes in tryp-
tophan solvent exposure observed in the simulation.
To test features of the model, we mutated residues predicted to interact with oleic acid (Figure 3—
figure supplement 1) and measured the relative inhibition constant (Krel, app) by dose response FP. 
We observed no change in fatty acid inhibition when Q30 was mutated to a glutamate (Krel, app = 0.9, 
Figure 3—figure supplement 1). Mutation of H83 to leucine also had no effect on fatty acid inhibition. 
Mutation of H83 to phenylalanine reduced inhibition by almost twofold. H83 lines the hydrophobic 
pocket. Mutation of this residue to phenylalanine is predicted to make the pocket narrower. Mutation 
of G64 to alanine reduced inhibition by 3.1-fold. G64 forms the floor of the hydrophobic pocket, muta-
tion to an alanine is expected to make the pocket more shallow. Mutation of G35 to aspartate and 
glutamate results in a twofold and sevenfold reduction of inhibition, respectively. This is possibly due 
to the addition of a negative charge near the mouth of the hydrophobic cavity.
To test whether the R53 and/or R61, which are predicted to interact with the carboxylate end 
of oleic acid, are important for inhibition, we made single glutamate mutations at each position 
(R53E or R61E). Oleic acid inhibition of the R53E mutant is reduced threefold, while R61E is reduced 
fivefold. Mutating both arginines (R53E/R61E) increases this effect to 35-fold. This indicates that 
R53 and R61 are both important for inhibition, and act in a partially redundant way. A triple mutant 
(R53E/R59E/R61E) weakens inhibition by a similar amount (27-fold). The R53E mutant has a small 
effect on RNA-binding, while the R61E mutant has a strong 18-fold effect. The interaction of R61 
with oleic acid would preclude its interaction with RNA, and thus may contribute to the mech-
anism of inhibition.
oleic acid-bound states of MSI1. The Lipari-Szabo order parameters for the backbone NH bond vectors, S2, were calculated to quantify the backbone 
flexibility of the free and oleic acid-bound form of MSI1. The difference of the order parameters, ΔS2 = S2apo−S2MSI−OA, indicates that MSI1-oleic acid 
complex is more flexible than apo MSI1, with the few exceptions mostly observed at the N-terminus. The secondary structural elements are highlighted 
at the top. Error bars are calculated from the standard deviation among trajectories.
DOI: 10.7554/eLife.02848.010
The following figure supplements are available for figure 3:
Figure supplement 1. Mutational analysis supports molecular dynamics simulation and docked model predictions. 
DOI: 10.7554/eLife.02848.011
Figure 3. Continued
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Figure 4. Molecular dynamics studies (A and B) represent the normalized histograms of the protein solvent accessible surface area (SASA) and radius of 
gyration (rgyr) illustrating the structural transition undergone by the MSI1 upon oleic acid binding. (A) SASA distributions calculated from the MD 
trajectories of MSI1 bound to oleic acid and of MSI1 in the apo state are represented in red and black, respectively. (B) Radius of gyration distributions 
calculated from the MD trajectories of MSI-1 bound to oleic acid and of MSI1 in the apo state are represented in red and black, respectively. (C) The probability 
of being in an α-helix or β-sheet is shown for each residue of MSI1. The probabilities calculated for each residue from the MD trajectories of MSI1 free 
and bound to oleic acid are shown in black and red, respectively. Oleic acid binding is associated with stabilization of the C-terminus of α-helix 1, fraying 
of α-helix 2, at both the N- and C-termini, extension of sheet 2, as well as the formation of an additional β-sheet at loop 5 (L5). (D and E) Normalized 
histograms of the distance between G35, located on α-helix 1, and L85, located on loop 5, calculated from the MD trajectories of oleic acid-bound MSI-1 
Figure 4. Continued on next page
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and of apo MSI1 are shown in red and black, respectively. The distribution of distances between the Cα atoms of G35 and L85 is depicted in (D). The 
distribution of distances between the Cα of G35 and the Cδ2 of L85 is shown in (E). The green lines show the values of these distances observed in the 
NMR structure of MSI1 bound to RNA (PDB ID 2RS2). In the oleic-bound state, loop 5 is restricted in approaching α-helix 1 due to the steric hindrance of 
the oleic acid. (F and G) Normalized histograms of two representative side chain distances of W29 and Q30. Histograms calculated over the MD 
trajectories of oleic acid-bound MSI1 are shown in red, those of apo MSI1 in black. The distance between W29 Cε2 and Q30 Cγ is shown in (F). The 
distance between W29 Cζ2 and Q30 Nε2 is shown in (G). The green lines show these distances observed in the NMR structure of MSI1 bound to RNA 
(PDB ID 2RS2). In the oleic-bound state, the side chain of W29 is stacked against the side chain of Q30. This conformation of W29 is not observed in 
either the free or RNA-bound states of MSI1.
DOI: 10.7554/eLife.02848.012
Figure 4. Continued
Together, the MD simulations and experimental 
data are consistent with an allosteric model of 
inhibition, wherein fatty acid binding induces a 
change in conformation that modifies the sec-
ondary structure of RRM1 and perturbs the pos-
ition of amino acids required for RNA recognition. 
Additional work will be necessary to determine 
whether fatty acid inhibition works via the mech-
anism suggested by the computational docking 
and MD simulations or through an alternative 
mechanism.
Oleic acid treatment reduces 
oligodendrocyte progenitor cell 
proliferation
To study the role of fatty acids in regulating MSI1 
in a cell culture model, we investigated the effect 
of treating the immortalized rat oligodendrocyte 
progenitor cell line CG-4 with oleic acid (Louis 
et al., 1992). CG-4 cells maintain normal pre-
cursor cell morphology, can be readily transfected, 
and can be induced to differentiate into mature 
oligodendrocytes by withdrawal of growth factors (Louis et al., 1992; Franklin et al., 1995). Mature 
oligodendrocytes produce myelin, a lipid-rich membrane structure that insulates neuronal axons 
to both protect them and to aid in saltatory impulse conductance throughout the CNS (Griffiths et al., 
1998). The lipid and fatty acid profiles of mature oligodendrocyte-rich white matter differ from that of 
the grey matter (Figure 5–figure supplement 3, Martinez and Mougan, 1998). CG-4 cells also shift 
lipid profiles upon differentiation, as detected by quantitative lipidomics mass spectrometry (Figure 5—
figure supplement 1). As with primary OPCs, MSI1 is expressed strongly in the precursor state but 
decreases upon differentiation (OPCs: 1.0 ± 0.3, oligodendrocytes: 0.15 ± 0.01, p-value=0.0035). 
Treatment of CG-4 OPCs with oleic acid strongly inhibited the rate of cell proliferation (Figure 5), 
matching the published phenotype of MSI1 knock down in primary OPCs (Dobson et al., 2008). In 
contrast, treating HEK293T cells—which do not express MSI1—with the same concentration of oleic 
acid had little or no effect on the rate of proliferation. Treatment with stearic acid, which does not 
inhibit MSI1, had no effect on proliferation rate in either cell type (Figure 5A). The data suggest that 
reduction of MSI1 activity by oleic acid limits proliferation, but we cannot rule out that the fatty acid 
modulates other cellular pathways that contribute to proliferation.
MSI1 regulates stearoyl-CoA desaturase
We hypothesized that MSI1 might control the expression of enzymes required to make long chain 
monounsaturated fatty acids. In humans, non-dietary oleic acid is produced from stearic acid by 
stearoyl-CoA desaturase (SCD). Expression of SCD is tightly controlled at the transcriptional, post-
transcriptional, and post-translational levels. In rodents, there are four SCD genes, Scd1-4. We used 
FP and F–EMSA assays to test the ability of recombinant MSI1 to bind each of seven putative 
consensus sites present in the Scd1 3′-UTR (Figure 5B). MSI1 binds to all seven sites by FP and 
Video 1. This video is a representative segment of an 
MD trajectory of MSI1 bound to oleic acid. 
DOI: 10.7554/eLife.02848.013
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Figure 5. MSI-1 regulates stearoyl-CoA desaturase. (A) HEK293T (dashed) and CG-4 (solid) cell proliferation as a function of oleic acid or stearic acid 
treatment (red = treated, black = untreated). The data are the average and standard deviation of at least three biological replicates. (B) There are seven 
MSI1 consensus sites in the 3′-UTR of Scd-1 mRNA. The Kd, app is the average and standard deviation of at least three experiments. (C) Scd-1 transcripts 
co-immunoprecipitate with anti-MSI1 antibodies. The data were quantified using a FUJI FLA-5000 imager. (D) Western analysis of SCD expression in 
HEK293T cells. The data were quantified using the LICOR Odyssey system relative to non specific bands (** and *, Figure 5—figure supplement 2B) to 
control for loading. The average and standard deviation of at least three independent experiments is shown. (E–H) Lipidomics analysis of HEK293T cells 
± MSI1 expression. Source data are included in Figure 5—source data 1. (E) Volcano plot of lipidomics data. Dashed lines denote fold-changes of ±1.5 
and ±3. Red data points indicate lipids that are significantly changed upon MSI1 expression. (F) Scatter plot of lipidomics data. Data are reported as 
nMoles per million cells. Red data points indicate lipids that are significantly changed upon MSI1 expression (FDR = 0.05). (G) Fold-changes of the total 
cholesterol esters and two TAG classes in which 38 of the 54 significantly changing lipids are categorized. Each class changes significantly with MSI1 
Figure 5. Continued on next page
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F–EMSA (Figure 5—figure supplement 2). Site 2 and site 7 bind to MSI1 with comparable affinity to 
the selected aptamer. The slightly decreased binding affinity measured for these 7 fragments is likely 
due to the fact that our aptamer CCCR005 contains two MSI1 binding sites, while each Scd1 3′-UTR 
fragment contains only a single MSI1 binding site. Transcripts encoding SCD1 co-immunopreciptated 
with MSI1 from CG-4 cell extracts using two independent antibodies (Figure 5—figure supplement 2C). 
Similar results were obtained with Numb mRNA, a positive control. Overexpression of MSI1 in HEK293T 
cells, which do not endogenously express MSI1, increased the amount of SCD and SCD proteolysis 
products by 2.5 ± 0.35-fold (p-value=0.018, Figure 5D, Figure 5—figure supplement 2B). We were 
unable to detect SCD expression in the rat CG-4 cells using available antibodies. qRT-PCR analysis of 
HEK293T mRNA shows a slight but non-significant increase in SCD1 transcript abundance upon MSI1 
overexpression (Figure 5—figure supplement 2C).
Next, we sought to assay downstream effects of SCD regulation by MSI1 in cells. We reasoned that 
because SCD plays an integral role in lipogenesis, changes in SCD activity would result in a shift in the 
cellular lipid profile. To this end, we performed quantitative lipidomics mass spectroscopy analysis. CG-4 
cell proliferation halts upon MSI1 knockdown (Dobson et al., 2008). For this reason, we performed 
these experiments in HEK293T cells with and without MSI1 expression. We observed statistically signifi-
cant changes ranging from 2- to 32-fold in 54 of the 312 lipids assayed (FDR = 0.05, Figure 5E,F). 
We noted positive changes in 50 of 54 significant data points, indicating that MSI1 expression stimulates 
production of certain lipids. 38 of the significantly changing lipids fell into one of three cholesterol and 
triacylgylcerol (TAG) classes: cholesterol esters, 16:0 acyl-containing TAG, and 16:1 acyl-containing 
TAG (Figure 5G,H). Cholesterol esters and TAGs are made using SCD products, and have been shown 
to be more abundant in mice overexpressing SCD1, and less abundant in liver SCD1 knockout mice 
(Miyazaki et al., 2000; Attie et al., 2002). This indicates that SCD activity is upregulated in the presence 
of MSI1. Together, our binding data, co-immunoprecipitation, western blots, and lipidomics profiling 
results show that stearoyl-CoA desaturase expression is increased in the presence of MSI1, possibly 
through direct association with consensus motifs in the 3′-UTR of SCD transcripts. We note that of 2107 
annotated 3′ UTRs for genes involved with lipid, cholesterol, fatty acid biosynthesis, and SREBP activity, 
1275 contain at least one MSI1 binding element. While the presence of a binding element does not 
confer regulation, MSI1 regulation of lipid metabolism may be more complex than simple direct regula-
tion of SCD. Indeed, a survey of 64 genes that associate with MSI1 in a RIP-ChIP experiment reveals that 
8 are annotated to be involved with lipid metabolic processes (de Sousa Abreu et al., 2009).
Discussion
Our data reveal that the long chain ω-9 fatty acids oleic acids between 18 and 22 carbons in length 
are allosteric inhibitors of MSI1 RNA binding activity. Our data also show that SCD, the enzyme that 
catalyzes the ω-9 desaturation, is a MSI1 regulatory target. The results are consistent with a model 
where MSI1 controls cellular proliferation through a feedback loop that includes SCD and its enzymatic 
products, such as oleic acid (Figure 6).
Oleic acid is the precursor for synthesis of longer chain fatty acids such as eicosanoic, erucic, and 
nervonic acid, signaling molecules such as arachidonic acid, endocannabinoids, and prostaglandins, 
and membrane phospholipids. Oleic acid is abundant in the lipid-rich myelin membranes produced 
overexpression (p<0.05). (H) Fold-changes for the four lipids that comprise the total cholesterol esters class. All display significant changes with MSI1 
expression (FDR = 0.05).
DOI: 10.7554/eLife.02848.014
The following source data and figure supplements are available for figure 5:
Source data 1. Lipidomics data files. 
DOI: 10.7554/eLife.02848.015
Figure supplement 1. Dose response for oleic acid treatment in cell culture. 
DOI: 10.7554/eLife.02848.016
Figure supplement 2. 
DOI: 10.7554/eLife.02848.017
Figure supplement 3. Lipidomics analysis of undifferentiated and differentiated CG4 oligodendrocyte progenitor cells. 
DOI: 10.7554/eLife.02848.018
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by mature oligodendrocytes (Martinez 
and Mougan, 1998), and CG-4 OPCs 
show global changes in the lipid 
profile upon differentiation. OPCs 
express MSI1, but mature myelinating 
oligodendrocytes do not (Dobson 
et al., 2008). In the oligodendrocyte 
lineage, oleic acid, and MSI1 levels 
are anti-correlated, which suggests 
a possible biological role for MSI1 
inhibition by fatty acids (Martinez and 
Mougan, 1998; Dobson et al., 2008). 
Another MSI1 inhibitor identified in 
our screen was the PPARα agonist 
GW7647. PPARs are nuclear hormone 
receptor proteins that regulate cel-
lular processes including fatty acid 
metabolism, differentiation, cell cycling, 
and inflammation (Berger and Moller, 
2002). PPARγ agonists accelerate oli-
godendrocyte maturation (De Nuccio 
et al., 2011). Both GW7647 and oleic 
acid function as PPAR agonists, and 
both inhibit MSI1 RNA-binding activity, 
suggesting that MSI1 and PPARs pos-
sibly regulate gene expression in a 
reciprocal fashion.
We have identified the metabolic 
enzyme SCD as regulatory target of 
MSI1. The two human isoforms of SCD, SCD1 and SCD5, catalyze the conversion of saturated fatty 
acids (SFAs) into monounsaturated fatty acids (MUFAs) (Zhang et al., 1999; Beiraghi et al., 2003; 
Minville-Walz et al., 2010). MUFAs are then used in the synthesis of numerous lipids, including 
phospholipids, di- and triacylglycerols, cholesterol esters, and signaling molecules such as eicosa-
noids. SCD is therefore an essential enzyme to normal cellular proliferation, metabolism, and signaling. 
It is also possible that MSI1 may be regulating other factors involved in lipid, fatty acid, and choles-
terol metabolism. The Penalva group identified 64 putative MSI1 targets using a RIP-ChIP analysis 
in HEK293T cells (de Sousa Abreu et al., 2009). Of these putative targets, eight are annotated to play 
a role in lipid, fatty acid, or cholesterol metabolic processes. These include three variants of the fatty 
acid elongase ELOVL5, two variants of the glycolipid biosynthetic factor PIGF, two variants of Lamin B 
receptor (LBR), and aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase 
(AASDHPPT).
SCD has been implicated in a number of disease states, including obesity, diabetes, hyperlipidemia, 
and cancer. Obese and diabetic animals produce abnormally high levels of TAGs and cholesterol esters 
(Coleman and Lee, 2004). These energy storage molecules are also elevated in a hyperlipidemia 
mouse model that overexpresses SCD (Attie et al., 2002). Conversely, SCD1 knockout mice display 
impaired biosythesis of both TAGs and cholesterol esters (Miyazaki et al., 2000). SCD is upregulated 
in tumor cells, including colonic and esophageal carcinoma (Li et al., 1994). Cancerous cells use newly 
synthesized lipids primarily for phospholipid production, which are used in new membranes (Swinnen 
et al., 2000). Additionally, new evidence suggests that SCD1 activates the oncogenic Akt and AMPK 
signaling pathways (Scaglia and Igal, 2008; Scaglia et al., 2009).
SCD regulates SFA and MUFA homeostasis, and therefore plays an integral role in lipid signaling 
pathways. SFAs serve as proinflammatory factors by acting as ligands for immune receptors such as 
those in the Toll-like receptor family (Shi et al., 2006; Nguyen et al., 2007). MUFA products of SCD 
are further modified to become polyunsaturated fatty acids, such as arachidonic acid, which are con-
verted into eicosanoids by cyclooxygenases (James et al., 2000). Eicosanoids serve as proinflammatory 
and immune signaling molecules (Liu et al., 2011). Recent data also link SCD to Wnt signaling through 
Figure 6. Model of SCD regulation by MSI1, and subsequent 
downstream consequences of SCD activity changes. 
DOI: 10.7554/eLife.02848.019
Biochemistry | Biophysics and structural biology
Clingman et al. eLife 2014;3:e02848. DOI: 10.7554/eLife.02848 16 of 26
Research article
mediation of the palmitic/palmitoleic acid conversion, as active Wnt proteins require conjugation of 
palmitoleic acid (Rios-Esteves and Resh, 2013). The balance between SFAs and MUFAs must be 
tightly controlled, and while SCD is not the only enzyme involved in the process, it does serve as an 
essential gatekeeper in the conversion of dietary SFA to MUFA.
Several examples of functional interactions between transcription factors and fatty acids have been 
published. For example, fatty acids associate with membrane-bound sterol responsive element binding 
protein (SREBP) to inhibit a cleavage event that produces the activated form of SREBP, a transcription 
factor involved in lipid homeostasis (Wang et al., 1994). Free fatty acids have been shown to stimulate 
proinflammatory cytokine expression while decreasing anti-inflammatory cytokine expression in 
adipocytes (Bradley et al., 2008). Interestingly, treatment of various tumor lines with oleic acid results 
in transcriptional inhibition of the Her-2/neu (erbB-2) oncogene through PEA3, although the precise 
mechanism of regulation remains unknown (Menendez et al., 2006). In yeast cells, fatty acids bind 
oleate-activated transcription factors (OAFs) to effect transcription of genes responsible for fatty 
acid metabolism, glucose metabolism, stress response, and other related processes (Gurvitz and 
Rottensteiner, 2006). Although numerous transcription factors are regulated by fatty acids, to our 
knowledge, MSI1 is the first example of a fatty acid-responsive RNA binding protein.
Integration of metabolite sensing and post-transcriptional regulation is widespread in bacteria, 
but relatively few examples have been found in eukaryotes (Winkler and Breaker, 2003; Roth and 
Breaker, 2009). Riboswitches regulate gene expression at the RNA level in response to intermediary 
metabolites. Small molecule metabolites bind mRNA transcripts, usually in the 5′ UTR, to induce a 
structural change that interferes with the transcriptional or translational machinery (Winkler and 
Breaker, 2005). In bacteria, riboswitches sensitive to a number of metabolites have been characterized, 
including guanine, adenine, coenzyme B12, glycine, lysine, and thyamine pyrophosphate (TPP), among 
others (Grundy et al., 2003; Mandal et al., 2003, 2004; Sudarsan et al., 2003; Vitreschak et al., 
2003; Mandal and Breaker, 2004). Although most riboswitches have been identified within the 
bacterial mRNA 5′ UTR, TPP riboswitches, have also been identified in plants and fungi (Kubodera et al., 
2003; Sudarsan et al., 2003). While riboswitches comprise an essential cis-regulatory mechanism in 
bacteria, other mechanisms of coupling metabolic state to post-transcriptional gene regulation may 
occur in eukaryotes.
An increasing number of protein-metabolite-RNA interactions have now been identified in bacteria 
and eukaryotes. One example is the Bacillus subtilis tryptophan RNA-binding attenuation protein 
(TRAP). Increasing intracellular tryptophan levels induce TRAP multimerization, which enables mRNA 
recognition and subsequent translational repression of targets (Gollnick et al., 1990; Antson et al., 
1995; Babitzke et al., 1995; Yakhnin et al., 2004). Intriguingly, several metabolic enzymes have been 
proposed to ‘moonlight’ as RNA-binding proteins in ‘RNA/Enzyme/Metabolite (REM)’ networks 
(Ciesla, 2006; Hentze and Preiss, 2010; Castello et al., 2012). A notable example is cytosolic 
aconitase, which demonstrates mutually exclusive enzymatic and RNA-binding functionality, depending 
upon cellular iron levels (Hentze and Argos, 1991; Rouault et al., 1991). A number of metabolite-
sensitive enzymes have also demonstrated RNA-binding activity, including GAPDH, glutamate dehy-
drogenase, thymidylate synthase, and dihydrofolate reductase (Ryazanov, 1985; Chu et al., 1991, 
1993; Preiss et al., 1993; Dollenmaier and Weitz, 2003). This growing body of research suggests 
that metabolite-mediated post-transcriptional regulation is much more prevalent than previously 
thought.
Our results show that MSI1 N-terminal RRM1 acts as a metabolite sensor, the first example of such 
activity observed for the most abundant RNA-binding motif in eukaryotic genomes. A survey of RRM 
structures in the protein data bank reveals several with a surface cavity on the alpha helical face, which 
may comprise metabolite-binding pockets. We predict that a network of RNA regulatory proteins act 
as metabolite sensors, possibly replacing the bacterial riboswitch regulation that appears to have been 
largely lost in eukaryotes.
Materials and methods
Plasmids
DNA encoding the mouse MSI1 RNA binding domain fragment (amino acids 7–192) was amplified 
from the mammalian gene collection (MGC) full-length ORF clone 100014969 (Invitrogen) using 
gene specific primers (forward primer: 5′-cgcgcggatcccagcccggcctcgcctcccc-3′; reverse primer: 
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5′-gcgcgaagcttcggggacatcacctcctttg-3′). This fragment was digested using BamHI and HindIII restric-
tion enzymes and subcloned into a modified version of pET-22b vector (Life Technologies, Grand 
Island, NY) in which the pelB leader sequence was replaced with a His6-Gly tag followed by a TEV 
protease site to make pET-22HT-MSI1 (7–192). Mutant versions of the MSI1 RNA binding domain 
were prepared by site-directed mutagenesis using QuikChange (Stratagene). The human MSI2 RNA 
binding domain fragment (amino acids 8–193) was amplified from MGC full-length ORF clone 3505639 
using gene specific primers (forward primer: 5′-cgcgcggatccggcacctcgggcagcgccaa-3′; reverse primer: 
5′-gcgcgaagctttcatgggaacatgacttctttcg-3′). This fragment was cloned into the BamHI and HindIII 
restriction sites of pET-22HT to make pET-22HT-MSI2 (8–193). The MSI1 RRM1 plasmid pET-22HT-MSI1 
(7–103) was prepared by site-directed mutagenesis using QuikChange (Stratagene) to replace M104 
with an ochre stop codon. Full-length mouse MSI1 was amplified from MGC full-length ORF clone 
100014969 (Life Technologies) using forward primer 5′-cgcgcggatccatggagactgacgcgcccca-3′ and 
reverse primer 5′-ccgggcggccgctcagtggtacccattggtgaa-3′. The resulting fragment was subcloned 
into pCDH-CMV-MCS-EF1-Puro (System Biosciences) using the BamHI and NotI restriction enzymes 
to make pCDH-CMV-MSI1(FL).
Purification of recombinant proteins
H6-TEV-MSI-1 (7-192), H6-TEV-MSI-1 (7-104), and H6-TEV-MSI-2 (8-294) were expressed and purified 
from Escherichia coli BL21(DE3) cells. Liquid cultures grown at 37°C were induced for 3 hr during mid-
log phase with 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG). Cells were pelleted, resuspended 
in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM Imidazole, 5 mM β-Mercaptoethanol [BME]), 
and lysed using a microfluidizer (IDEX Health and Science). Soluble lysate was applied to a Ni-NTA 
column (Qiagen), washed with wash buffer (50 mM NaH2PO4, 300 mM NaCl, 50 mM Imidazole, 5 mM 
BME), and eluted with elution buffer (50 mM NaH2PO4, 300 mM NaCl, 300 mM Imidazole, 5 mM BME). 
Fractions were analyzed by SDS-page and those containing recombinant MSI1 or MSI2 were pooled 
and dialyzed overnight into S buffer (50 mM MOPS pH 6.0, 20 mM NaCl, 2 mM DTT). Pooled fractions 
were applied to a HiTrap SP cation exchange column (GE Healthcare) and eluted using a gradient of 
0.1 M–1 M NaCl in S Buffer. Fractions containing MSI1 or MSI2 were pooled and dialyzed overnight 
into Q buffer (50 mM Tris pH 8.8, 20 mM NaCl, 2 mM DTT) prior to loading a HiTrap Q anion exchange 
column (GE Healthcare). The protein was eluted over a gradient from 0.1 to 1 M NaCl in Q buffer. 
Fractions containing MSI were pooled and dialyzed using Spectra/Por 7 25 kD (MSI1) or 10 kD (MSI2) 
molecular weight cutoff tubing (Spectrum laboratories) overnight into storage buffer (50 mM Tris pH 
8.0, 20 mM NaCl, 2 mM DTT). The yield of >95% pure MSI1 or MSI2 is typically 20 mg per liter of 
culture (Figure 1—figure supplement 1).
RNA sequences and labeling
Synthetic RNA oligonucleotides were ordered from IDT and 3′ end-labeled with fluorescein 
5-thiosemicarbazide (Life Technologies) according to the method of Reines and Cantor (Reines and 
Cantor, 1974; Pagano et al., 2007; Farley et al., 2008). Briefly, 5 × 10−10 mol of RNA were incubated 
with 100 mM NaOAc, pH 5.1, and 5 nmol of NaIO4 for 90 min at room temperature then ethanol 
precipitated. The RNA was resuspended in 50 µl of 1 mM fluorescein-5-thiosemicarbazide in 100 mM 
NaOAc, pH 5.1. After incubating overnight at 4°C, the RNA was separated from unreacted label by 
ethanol precipitation and subsequently passaged through a Pierce centrifuge column packed with 
Spehadex G-25 resin (GE Healthcare). RNA CCCR005 was a truncated form of the SELEX aptamer 
S8-13 identified by the Okano lab (Imai et al., 2001). In preparation for the small molecule screen, 
fCCCR005 (AGCGUUAGUUAUUUAGUUCG/36-FAM/) was ordered pre-labeled from IDT.
Fluorescence polarization and electrophoretic mobility shift assays
Fluorescence polarization (FP), also known as fluorescence anisotropy, and Fluorescence electropho-
retic mobility shift assays (F–EMSA) were used to measure the binding affinity of recombinant MSI1 
to fluorescein-labeled RNA aptamers. Assays were conducted as described in Pagano et al. (2011). 
Briefly, 2 nM fluorescein-labeled RNA was incubated with varying concentrations of recombinant 
purified MSI1 protein in equilibration buffer (37.5 mM Tris pH 8.0, 75 mM NaCl, 0.0075% igepal, 
0.0075 mg/ml tRNA) for 3 hr. Fluorescence polarization was determined with a Victor V3 plate reader 
using a 480 ± 31 nm excitation filter and a 535 ± 40 nm emission filter. After measuring FP, the samples 
were mixed with 6 ×x bromocresol green loading dye (0.15% (wt/vol) Bromocresol green, 30% 
(vol/vol) glycerol) and run on a 5% native polyacrylamide gel at 120 V for 75 min at 4°C. Wet gels were 
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scanned with a Typhoon FLA 9000 Biomolecular imager (GE healthcare) using a 473 nm laser and a 
long-pass cut-off filter (510 nm). The fraction of bound RNA was determined by quantifying lower 
(free) and upper (bound) band intensities using MultiGauge and ImageGauge software (Fujifilm). 
For RNA sequences with two shifted species, the bands were quantified together.
Polarization values or the fraction of bound RNA were plotted as a function of protein concentration 
and fit to the Hill Equation 1 to determine the apparent dissociation constant (Kd) and the apparent Hill 
coefficient (n). The upper (m) and lower (b) values were also fit in order to define the assay window.
[ ]( )
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 (1)
For RNA sequences where a bi-phasic transition was observed, the FP data were fit using a two-site 
model (Equation 2) to determine both apparent dissociation constants (Kd1 and Kd2) and the fraction 
(F) of signal that corresponds to each transition.
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Small molecule screen
The small molecule screen was performed at the UMass Medical School small molecule screening core 
facility using a variation of the FP assay described above. 100 nM recombinant MSI1 protein and 2 nM 
fluorescein-labeled RNA aptamer CCCR005 were added to each assay well of 384-well black plates 
(Corning) using a μFill liquid dispenser (BioTek). Compounds dissolved in DMSO from the LOPAC 
and Chembridge libraries of small molecules were spotted in each assay well to a final concentration 
of 384 µM using a Tecan genesis workstation 150. 64 wells of each plate were reserved for controls, 
including 32 wells that included no protein and no compound (free RNA), and 32 wells that included 
protein, RNA, and DMSO (no compound). The plates were equilibrated at 25°C prior to collecting 
polarization and fluorescence intensity data for each well using a Victor V2V plate reader (Perkin Elmer). 
The Z′ score, a measure of signal-to-noise, was calculated for each plate using the average (µ) and 
standard deviation (σ) of the control wells (Equation 3).
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Plate reads with a Z′ of <0.5 were repeated. The average Z′ of all plates was 0.7 ± 0.2. The polari-
zation values (mP) of each well were normalized against the assay window using the mean polarization 
values of the no protein control (µ2) and no compound control (µ1) wells to generate an assay score 
(Equation 4).
μ
μ μ
2
1 2
–
=
–
mP
Score  (4)
Hits were classified as wells with a score of 0.1 or less where the fluorescence intensity remained within 
twofold of the control average to eliminate false positives due to compound fluorescence or quenching.
Dose response experiments
Dose response experiments to assess inhibition activity were performed using a modified FP and 
F–EMSA protocol. A constant concentration of sub-saturating protein was equilibrated with 2 nM 
fluorescein-labeled RNA and varying concentrations of compound in equilibration buffer. The FP and 
F–EMSA data were collected as above and fit to a sigmoidal dose response equation to determine the 
IC50 (Equation 5).
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The apparent inhibition constant was calculated using the Lin and Riggs conversion (Equation 6), 
which corrects for the equilibrium dissociation constant of MSI1 for the labeled RNA as well as the 
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concentration of labeled RNA and protein used in the experiment (Lin and Riggs, 1972; Ryder and 
Williamson, 2004).
Ki,app =
2(Kd)(IC50)
2P − R − 2Kd
 (6)
Intrinsic tryptophan fluorescence assay
To directly assay the association of fatty acids and MSI1 protein, 6 µM MSI1 or N-acetyl-tryptophanamide 
(NATA) was incubated with varying concentrations of compound. Equilibrated reactions were excited 
at 280 nm, then steady-state fluorescence emission spectra were recorded between 295 and 400 nm 
in 1 nm intervals using a T-format Fluorolog fluorimeter (Horiba). 350 nm emission data were normalized 
and fit to a quadratic bimolecular association curve (Equation 7) to determine the apparent dissociation 
constant, where C is the total compound concentration, P is the total protein concentration, and 
m and b represent the maximal and minimal signal, respectively.
( ) ( )
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d d
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In-silico docking analysis
The ligand molecules were downloaded from the PubChem database (pubchem.ncbi.nlm.nih.gov) 
and prepared for docking using the LigPrep module in Maestro (Schrödinger, LLC). The target 
protein structures were downloaded from the PDB (www.rcsb.org) and prepared for docking in 
Maestro (Schrödinger, LLC) using the Protein preparation wizard. Glide (Schrödinger, LLC) was used 
to generate the receptor grid for subsequent docking and scoring the docked ligands in Standard 
Precision (SP) mode. The pose with best Glide score from each ligand/receptor docking run was 
selected for further analysis (Friesner et al., 2004; Halgren et al., 2004; Friesner et al., 2006).
NMR
Labeling with 15N was performed by growing cells in isotopically enriched M9 medium, 1 g 15NH4Cl per 
liter. 2D 1H-15N HSQC spectra were collected using samples of U-15N MSI1 in 90% H2O/10%D2O buffer 
solution of 50 mM Tris at pH 7.0. 2D 1H-15N HSQC spectra were collected for each incremental addi-
tion of the unlabeled ligand (either aptamer RNA, oleic acid, or elaidic acid) to the 15N MSI1 sample 
to determine amide proton chemical shift changes upon titration of the ligand. All experiments were 
performed at 600 MHz on a Varian Inova spectrometer equipped with a triple-resonance cold probe 
at 298 K. Data processing was performed using NMRPipe (Delaglio et al., 1995) and sparky (Goddard 
and Kneller) software.
Molecular dynamics simulation
We performed molecular dynamics (MD) simulations of the RRM1 domain of MSI1 (residues 20–96) 
free and bound to oleic acid. We modeled the unknown structure of MSI1 bound to oleic acid by 
starting from the NMR solution structure of MSI1 RRM1 (Miyanoiri et al., 2003; Ohyama et al., 2011) 
and docking the oleic acid ligand using the GLIDE software package from Schrödinger, LLC (Friesner 
et al., 2006), followed by energy minimization and equilibration. All structures were solvated and 
neutralized in a TIP3P water box (Jorgensen et al., 1986). Energy minimization and MD simulations 
were subsequently carried out using the NAMD software package (Phillips et al., 2005) and using the 
version 27 CHARMM potential energy function (MacKerell et al., 1998). The particle mesh Ewald 
method (Darden et al., 1993; Essmann et al., 1995) was used to treat electrostatic interactions and 
periodic boundary conditions were applied throughout. The SHAKE algorithm (Ryckaert et al., 1977) 
was applied throughout the simulation to constrain the hydrogen atom bond lengths at their equilibrium 
values and an integration time step of 2 fs was used. After an initial energy minimization, the system 
was simulated in the isothermal-isobaric ensemble. Non-bonded interactions were calculated 
every time step using a cut-off distance of 12 Å. After equilibration in the isothermal-isobaric ensemble, 
an additional stage of equilibration was performed in the microcanonical ensemble. We then collected 
three independent 30 ns constant-NVE production runs of MSI-1 bound to oleic acid and one for 
MSI-1 in the free-state at an average temperature of 298 K.
Visualization and secondary structure analysis was performed in VMD, using the STRIDE method 
(Frishman and Argos, 1995).
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In addition, we employed a number of measures to characterize the structural and dynamical 
changes between the free and bound state of MSI-1, including the radius of gyration, the solvent 
accessible surface area (SASA), distance between backbone and/or side chain atoms of residues G35-
L85 and W29-Q30, and Lipari and Szabo order parameters (Lipari and Szabo, 1982; Humphrey et al., 
1996). These quantities were calculated using VMD (Humphrey et al., 1996) software along with 
bespoke programs previously described elsewhere (Morgan and Massi, 2010).
Circular dichroism
Far-UV circular dichroism (CD) spectra were collected using 10 µM MSI1 in 50 mM Tris pH 8.0, 100 mM 
NaCl, and 0.1% TFE on a Jasco-810 spectropolarimeter (Jasco Inc., Easton, MD). Spectra were col-
lected from 215 to 260 nm in a 0.2-cm path length quartz cuvette using a scan rate of 20 nm min−1 and 
a response time of 8 s. The sample temperature for all CD measurements was maintained at 293 K.
Analytical ultracentrifugation
Sedimentation velocity analyses were conducted using a Beckman Optima XL-I analytical ultracentri-
fuge in the University of Massachusetts Medical School Ultracentrifuge Facility. Data were analyzed 
with UltraScan III version 1.0 (Demeler et al., 2011). Sedimentation velocity experiments were per-
formed with 45 µM MSI1 in storage buffer (50 mM Tris-HCl pH 8.0, 20 mM NaCl, 2 mM DTT). 
Measurements were made at 20°C using an AN60ti rotor at 20,000 rpm and 280 nm in intensity mode. 
Partial specific volumes were estimated on the basis of peptide sequence with UltraScan and found to 
be 0.7280 cm3/g for the MSI1 RBD. Data were analyzed by two-dimensional spectrum analysis with 
simultaneous removal of time and radially invariant noise (Demeler et al., 2009; Brookes et al., 2010). 
Noise and diffusion-corrected, model-independent sedimentation coefficient distributions were gen-
erated using the enhanced van Holde–Weischet analysis (Demeler et al., 1997; Demeler and van 
Holde, 2004).
Cell-based experiments
Cell lines and culture
CG-4 rat oligodendrocyte progenitor and B104 neuroblastoma cells were a gift from Lynn Hudson and 
were cultured as previously described (Louis et al., 1992). CG-4 cells were maintained in the progen-
itor state in 30% B104 conditioned media. HEK293T cells were cultured in Dulbecco's modified Eagle's 
medium (Life Technologies) with 10% fetal bovine serum (Atlanta Biologicals Inc., Lawrenceville, GA), 
100 units/ml penicillin, and 100 µg/ml streptomycin (Invitrogen).
Proliferation assays
100,000 HEK293T or CG-4 cells were seeded into each well of six-well culture plates. 24 hr after 
seeding, cells were treated with either 50 µM oleic acid in EtOH or EtOH only as a control. 24, 48, and 
72 hr after fatty acid treatment, cells were assayed for proliferative changes using the Cyquant direct 
cell proliferation assay (Life Technologies) according to the manufacturer's instructions using a Victor 
V3 plate reader (PerkinElmer). The treatment concentration was chosen after a dose response for tox-
icity and efficacy across a range defined by established protocols for neuroblastoma cells (Figure 5—
figure supplement 1; Di Loreto et al., 2007).
RNA co-immunoprecipitation
For each experiment, 106 CG-4 cells were crosslinked for 10 min with 0.1% formaldehyde in PBS then 
scraped into lysis buffer (1% [wt/vol] SDS, 10 mM EDTA, 1 ×x EDTA-free protease inhibitors). Lysate 
was diluted in 10X IP buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris–HCl, pH 8.1, 
167 mM NaCl) with 8 units SUPERase-In (Ambion). Immunoprecipitation was performed using rabbit 
polyclonal anti-Musashi 1 (ab21628; Abcam) or rabbit polyclonal anti-GFAP (ab7260; Abcam) con-
jugated to Dynabeads protein G (Life Technologies) according to the manufacturer's instructions. 
After proteinase K digestion (NEB) and heat-induced crosslink reversal, RNA was phenol–chloroform 
extracted, ethanol precipitated, and resuspended in 20 µl nuclease-free water. RNA was then treated 
with DNase (Ambion Turbo DNAfree) to remove any DNA contamination. RNA was reverse transcribed 
and amplified using a SuperScript III One-Step RT-PCR System with PlatinumTaq (Life Technologies) 
and transcript-specific fluorescein-labeled primers for scd1 and numb. PCR products were separated 
from free primers on a 5% native polyacrylamide gel, imaged on a Fuji FLA-5000 imager, and quanti-
fied using Image Gauge software.
Biochemistry | Biophysics and structural biology
Clingman et al. eLife 2014;3:e02848. DOI: 10.7554/eLife.02848 21 of 26
Research article
MSI1 overexpression and qRT-PCR
24 hr prior to transfection, 106 HEK293T cells were seeded in 10-cm culture plates. The cells were 
transfected with 2 µg pCDH-CMV-MSI1(FL) or empty pCDH-CMV-MCS-EF1-Puro using Effectine 
reagent according the manufacturer's instructions (Qiagen). 24 hr after transfection, transfected cells 
were selected for with 2 µg/ml puromycin (Sigma). RNA and protein were harvested 72 hr after trans-
fection. To confirm MSI1 overexpression, RNA was collected using Trizol reagent (Life Technologies) 
followed by DNAse treatment (Turbo DNAfree, Ambion) according to the provided instructions. RNA 
yield was determined by spectrophotometry and quantitative RT-PCR was performed with an Opticon 
thermal cycler (Bio-Rad) using an iScript One-Step RT-PCR Kit with SYBR Green (Bio-Rad) according to 
the manufacturer's instructions. All assays were performed in triplicates. Data were analyzed by sig-
moidal curve fitting according to the method of Rutledge (2004) and normalized to GTF2i or Tubulin.
SCD western blots
Cells were lysed with SDS lysis buffer (1% SDS, 10 mM EDTA, 1x EDTA-free protease inhibitors) and 
protein concentration was determined by the bicinchoninic acid assay method (BCA, Pierce) according 
to the manufacturer protocol. Samples were boiled for 5 min after the addition of 6 ×x Laemmli buffer 
(9% SDS and 60% glycerol, 375 mM Tris-HCl pH 6.8, 0.015% Bromophenol blue, 12% β-mercaptoethanol). 
Proteins were separated for 2 hr on a 12% SDS-polyacrylamide gel using a Bio-Rad mini-PROTEAN 
electrophoresis apparatus, transferred to low-fluorescence PVDF membranes (Millipore) for 2 hr at 4°C 
at a constant 70 V in 25 mM Tris, 150 mM glycine, and 10% (vol/vol) methanol transfer buffer, blocked 
with Odyssey Blocking Buffer (OBB, LI-COR Biosciences) for 1 hr at room temperature, and probed 
with 1:1000 dilution of mouse monoclonal anti-SCD antibody (ab19862; Abcam) in OBB overnight at 
4°C. After washing with PBS-T, membranes were incubated with fluorescent goat anti-mouse sec-
ondary antibodies (926-32210; LI-COR Biosciences) at 1:15000 in OBB for 1 hr at room temperature. 
Signal was detected using an Odyssey Infrared Imaging System (LI-COR Biosciences). To ensure anti-
body specificity, shRNA knockdown of SCD1 was performed with two independent shRNA constructs 
(V3LHS_305870 and V3LHS_305872; Open Biosystems) and compared with non-silencing shRNA con-
struct (RHS4346; Open Biosystems).
Total lipid extraction
Cells were removed from plates with 0.25% Trypsin-EDTA (Gibco) and the total cell number was obtained 
using a hemocytometer. Each sample contained 1−2 × x106 cells. After pelleting by centrifugation, cells 
were resuspended in 200 µl H20, immediately followed by 250 µl methanol and 125 µl chloroform/0.01% 
Butylated hydroxytoluene (BHT). Samples were shaken vigorously for 30 s, then an additional 250 µl 
chloroform/0.01% BHT and 250 µl H20 was added. After 30 s of additional shaking, samples were cen-
trifuged for 5 min at 4°C. The chloroform layer was removed to a new tube, and the cell sample was 
treated with 250 µl of chloroform/0.01% BHT, vigorous shaking, centrifuging and subsequent chloro-
form layer removal twice more. Combined chloroform layers were washed with 500 µl KCL, then 500 µl 
H2O. Insoluble layers were transferred to glass vials and dried under argon. Samples were sent to the 
Kansas lipidomics research center for analysis by mass spectrometry as previously described (Welti 
et al., 2002). Five independent biological replicates were analyzed for each treatment group.
Lipidomics data analysis
The lipid profile data were acquired at Kansas Lipidomics Research Center (KLRC). Instrument acquisi-
tion and method development at KLRC was supported by NSF grants MCB 0455318, MCB 0920663, 
DBI 0521587, DBI 1228622, Kansas INBRE (NIH Grant P20 RR16475 from the INBRE program of 
the National Center for Research Resources), NSF EPSCoR grant EPS-0236913, Kansas Technology 
Enterprise Corporation, and Kansas State University. Lipidomics data were reported as nMoles/1 × 106 
cells. After removing data points for samples with values below the limit of detection for the instru-
mentation (0.02 nMoles/1 × 106 cells), all data points for which no signal was detected in either treat-
ment group were removed. A pseudocount of 0.002 nMoles/1 × 106 cells was added to all remaining 
data points. Outliers were eliminated using a Q test. Significant differences between treatments for 
each lipid class were determined using a Student's t test and an FDR of 0.05.
Critical micelle concentration determination
The critical micelle concentration (CMC) for oleic acid in equilibration buffer was determined using 
N-phenyl-1-naphthylamine (NPN), a compound that fluoresces when sequestered into micelles (Hagihara 
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et al., 2002; Hasegawa et al., 2008). 25 µM NPN was incubated with varying amounts of oleic acid 
for 30 min. Fluorescence intensity was determined with a Victor V3 plate reader using a 355 nm excitation 
filter and a 460 nm emission filter. Fluorescence intensity data were plotted as a function of fatty acid 
concentration. The CMC was determined by a two state segmented linear regression to identify the 
breakpoint between baseline fluorescence and fluorescence caused by NPN association with micelles.
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